Skip to main
XYL

Xylem (XYL) Stock Forecast & Price Target

Xylem (XYL) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 45%
Hold 27%
Sell 0%
Strong Sell 0%

Bulls say

Xylem is a well-positioned and fundamentally strong company with a solid strategy to drive portfolio improvement, growth, and margin expansion. The company has a global presence and a diversified portfolio serving various sectors, providing stability and growth prospects. The company's strong financials, including revenue of $9 billion in 2025 and a strong balance sheet, offer potential upside for investors, making it a good long-term investment opportunity.

Bears say

Xylem is facing challenges with delayed project orders and difficulty with parsing out accurate information from bookings and backlog reporting. The focus on water meters may have caused investors to overlook a large BOO project in WSS, which could provide margin accretion in 2H26. While the company has shown signs of margin expansion and organic growth, concerns about overhang remains as the heavy lifting on 80-20 "walk away" revenue in 1H26 may impact margins. Additionally, Xylem's operating performance has improved since the Evoqua merger, but there is still a sizable margin gap with its peers.

Xylem (XYL) has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 45% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Xylem and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Xylem (XYL) Forecast

Analysts have given Xylem (XYL) a Buy based on their latest research and market trends.

According to 11 analysts, Xylem (XYL) has a Buy consensus rating as of Sep 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $153.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $153.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Xylem (XYL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.